SynopsisThe DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with the.....
SynopsisRivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of.....
SynopsisAnesthesia circuits are utilized for a variety of diagnostic and therapeutic surgical procedures to deliver anesthetic agents and oxygen. The device serves as an interface between the anesthesia machine and the patient. Surgical procedures vary from cardiovasc.....
SynopsisAdenosine is a purine nucleoside used for conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PVST). Adenosine Injection is a rapid intravenous injection used as cardiovascular drugs and antiarrhythmic agents. The global Adenosine Inje.....
SynopsisThe Mask Meltblown Nonwoven Fabric market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market p.....
SynopsisThe Hematologic Malignancies Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global mark.....
SynopsisThe Metastatic Malignant Melanoma Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global m.....
SynopsisMalar implant is a facial implant designed to enhance the appearance of the cheekbones for aesthetic purposes. The global Malar Implant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % durin.....
SynopsisAntihemorrhagic Agent is a substance that promotes hemostasis (stops bleeding). The global Antihemorrhagic Agent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significan.....
SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market size is expected to reach US$ 331.5 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is ma.....
